Cypress Capital’s Pediatrix Medical MD Stock Holding History

Cypress Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6	Closed	-$45	–	237
2024 Q2	$45	Buy	+6	New	+$50	﹤0.01%	384
2021 Q3	–	Sell	-6	Closed	–	–	206
2021 Q2	$0	Hold	6	–	–	﹤0.01%	98
2021 Q1	$0	Buy	+6	New	+$154	﹤0.01%	116

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Cypress Capital's MD Position: Q3 2024 in Review

Cypress Capital sold out of Pediatrix Medical (MD) in Q3 2024, closing a stake of 6 shares — an estimated $45 sold.

Cypress Capital first reported a position in MD in Q1 2021 and held it in 3 quarters. The position peaked at $45 in Q2 2024. 218 funds tracked by Wall St. Rank hold MD as of Q3 2024.

Cypress Capital reported no remaining Pediatrix Medical position as of Q3 2024 after selling out during the quarter.
Cypress Capital sold 6 Pediatrix Medical shares in Q3 2024, an estimated $45.
Cypress Capital first reported a position in Pediatrix Medical in Q1 2021 and held it in 3 quarters.
Cypress Capital's Pediatrix Medical position peaked at $45 in Q2 2024.
218 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2024.

Based on Cypress Capital's 13F filing for Q3 2024, filed 12 Nov 2024.